Establishing (177)Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate Cancer

Clinical (177)Lu-PSMA-617 radioligand therapy (RLT) is applied in advanced-stage prostate cancer. However, to the best of our knowledge murine models to study the biologic effects of various activity levels have not been established. The aim of this study was to optimize specific and total activity...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Nucl Med
Hoofdauteurs: Fendler, Wolfgang P., Stuparu, Andreea D., Evans-Axelsson, Susan, Lückerath, Katharina, Wei, Liu, Kim, Woosuk, Poddar, Soumya, Said, Jonathan, Radu, Caius G., Eiber, Matthias, Czernin, Johannes, Slavik, Roger, Herrmann, Ken
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Society of Nuclear Medicine 2017
Onderwerpen:
Theranostics
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944167/
https://ncbi.nlm.nih.gov/pubmed/28546332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.193359
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items